HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Virus and Cancer
Virus and Cancer
Viruses are microscopic 'organisms' that infect the cells of other animals and plants. Human cancer has been related to a number of viruses. When viruses cause an infection, their DNA spreads throughout the body, altering the genetic makeup of healthy cells and potentially leading to cancer. Viruses have been found to play a role in the biology of multistep oncogenesis and are linked to a number of cancer manifestations. Virus infections are thought to be responsible for 15–20 percent of all human cancers. Vaccines to help prevent specific human cancers have been developed as our knowledge of the role of viruses as a cause of cancer has expanded.
- Human tumor viruses
- Epstein-Barr virus (EBV)
- Human Papilloma Viruses (HPV)
- Hepatitis B virus (HBV)
- hepatitis C virus (HCV)
- Human immunodeficiency virus (HIV)
- Human herpes virus 8 (HHV-8)
- Other Oncogenic viruses
- Vaccines and Its Development
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Thomas J Webster
Northeastern University, United States CIOC 2026 Speakers
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Nanomedicine in humans: 30 years of fighting diseases
Thomas J Webster, Northeastern University, United States
Title : Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27-year-old man
Moataz Taha Mahmoud Abdelsalam, Madinah Cardiac Center, Saudi Arabia
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation